Jump to content

Johnson & Johnson begins Phase III clinical trial for a COVID-19 vaccine


tacobell fan

Recommended Posts

The American company has begun the massive final stage of clinical trials for its single-dose COVID-19 vaccine. If the trial shows the vaccine is safe and effective, Johnson & Johnson anticipates the first batches of the vaccine will be available "for emergency use authorization in early 2021."

EinET-DXcAIM8SX?format=jpg&name=medium

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...